Effect of age on susceptibility to azoxymethane-induced colonic aberrant crypt foci formation in C57BL/6JNIA mice.

To determine the effect of age on susceptibility to azoxymethane (AOM)-induced colonic aberrant crypt foci (ACF) formation and its underlying mechanism, young and old mice were injected with AOM weekly for 4 or 5 weeks and euthanized 5 or 6 weeks later. Given the same (12 or 15) mg/kg body weight dose of AOM, old mice had significantly more ACF than young mice. However, given the same total dose of AOM (to avoid confounding effect of higher dose to heavier old mice), at a low total dose (1.5 mg) there was no age difference, but at higher total doses (1.8 and 2.2 mg) young mice had significantly more ACF than old mice. These results indicate that the age-related susceptibility to AOM differs depending on whether administration of the carcinogen is based on weight or total dose. These age differences are not due to variations in cyclooxygenase-2 expression, cell proliferation, or AOM hydroxylase activity.

[1]  S. Narumiya,et al.  Involvement of prostaglandin E receptor subtype EP(4) in colon carcinogenesis. , 2002, Cancer research.

[2]  H. Itoh,et al.  Age-associated increase of 8-hydroxydeoxyguanosine in human colorectal tissue DNA. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.

[3]  Aging is associated with increased proliferation and decreased apoptosis in the colonic mucosa , 2001, Mechanisms of Ageing and Development.

[4]  J. Alexander,et al.  Age-dependent induction of aberrant crypt foci in rat colon by 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine and azoxymethane. , 2000, Pharmacology & toxicology.

[5]  T. Sugimura,et al.  Altered expression of beta-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis. , 2000, Carcinogenesis.

[6]  S. Narumiya,et al.  Role of the prostaglandin E receptor subtype EP1 in colon carcinogenesis. , 1999, Cancer research.

[7]  R. Jaszewski,et al.  Aging and cancer of the stomach and colon. , 1999, Frontiers in bioscience : a journal and virtual library.

[8]  P. Guilloteau,et al.  Development of gastrointestinal and pancreatic functions in mammalians (mainly bovine and porcine species): influence of age and ingested food. , 1999, Reproduction, nutrition, development.

[9]  C. J. Barnes,et al.  Chemoprevention of spontaneous intestinal adenomas in the adenomatous polyposis coli Min mouse model with aspirin. , 1998, Gastroenterology.

[10]  S. Meydani,et al.  Enhanced expression of inducible cyclooxygenase with age in murine macrophages. , 1997, Journal of immunology.

[11]  N. Yoshimi,et al.  Apoptosis Induced by NS‐398, a Selective Cyclooxygenase‐2 Inhibitor, in Human Colorectal Cancer Cell Lines , 1997, Japanese journal of cancer research : Gann.

[12]  Dayong Wu,et al.  Macrophage prostaglandin production contributes to the age-associated decrease in T cell function which is reversed by the dietary antioxidant vitamin E , 1997, Mechanisms of Ageing and Development.

[13]  Bruno C. Hancock,et al.  Suppression of Intestinal Polyposis in Apc Δ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2) , 1996, Cell.

[14]  S. Bull,et al.  Natural history of aberrant crypt foci. A surgical approach. , 1996, Diseases of the colon and rectum.

[15]  K. Seibert,et al.  Advances in Brief Evaluation of Cyclooxygenase-2 Inhibitor for Potential Chemopreventive Properties in Colon Carcinogenesis ' , 2006 .

[16]  S. Bull,et al.  Natural history of aberrant crypt foci , 1996 .

[17]  A. Spigelman,et al.  Tissue prostaglandin levels in familial adenomatous polyposis patients treated with sulindac , 1996, Diseases of the colon and rectum.

[18]  V. Steele,et al.  Aberrant crypts as a biomarker for colon cancer: evaluation of potential chemopreventive agents in the rat. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[19]  R. DuBois,et al.  Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. , 1996, Gastroenterology.

[20]  T. Tseng,et al.  Promotion of colon carcinogenesis through increasing lipid peroxidation induced in rats by a high cholesterol diet. , 1996, Cancer letters.

[21]  R. Sjödahl,et al.  Cyclooxygenase-1 and cyclooxygenase-2 gene expression in human colorectal adenocarcinomas and in azoxymethane induced colonic tumours in rats. , 1996, Gut.

[22]  山下 直行.  Increased cell proliferation of azoxymethane-induced aberrant crypt foci of rat colon , 1996 .

[23]  S Jothy,et al.  Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. , 1995, Cancer research.

[24]  J. Neoptolemos,et al.  Lipid peroxidation and prostaglandins in colorectal cancer , 1994, The British journal of surgery.

[25]  A. Medline,et al.  Dose response and proliferative characteristics of aberrant crypt foci: putative preneoplastic lesions in rat colon. , 1991, Carcinogenesis.

[26]  A. Medline,et al.  Sequential analyses of the growth and morphological characteristics of aberrant crypt foci: putative preneoplastic lesions. , 1991, Cancer research.

[27]  J. Peggins,et al.  Age-related changes in biotransformation of azoxymethane and methylazoxymethanol in vitro. , 1990, Xenobiotica; the fate of foreign compounds in biological systems.

[28]  H. Pitot.  Aging and cancer: some general thoughts. , 1989, Journal of gerontology.

[29]  P. Holt,et al.  Colonic proliferation is increased in senescent rats. , 1988, Gastroenterology.

[30]  L. Roncucci,et al.  The influence of age on colonic epithelial cell proliferation , 1988, Cancer.

[31]  R. Bird,et al.  Aberrant crypts: potential preneoplastic lesions in the murine colon. , 1988, Cancer research.

[32]  M. Lipkin.  Biomarkers of increased susceptibility to gastrointestinal cancer: new application to studies of cancer prevention in human subjects. , 1988, Cancer research.

[33]  Pomila Singh,et al.  The effect of aging on the growth of colon cancer , 1987, Mechanisms of Ageing and Development.

[34]  E. Fiala,et al.  Inhibition of the metabolism of the colon carcinogen, azoxymethane, by pyrazole. , 1978, Cancer research.

[35]  E. Fiala.  Investigations into the metabolism and mode of action of the colon carcinogens 1,2‐dimethylhydrazine and azoxymethane , 1977, Cancer.